Protection against Mucosal Simian Immunodeficiency Virus SIV mac251 Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting
Open Access
- 1 March 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (5) , 2212-2221
- https://doi.org/10.1128/jvi.78.5.2212-2221.2004
Abstract
Whereas several recent AIDS vaccine strategies have protected rhesus macaques against a pathogenic simian/human immunodeficiency virus (SHIV)89.6P challenge, similar approaches have provided only modest, transient reductions in viral burden after challenge with virulent, pathogenic SIV, which is more representative of HIV infection of people. We show here that priming with replicating adenovirus recombinants encoding SIV env/rev, gag, and/or nef genes, followed by boosting with SIV gp120 or an SIV polypeptide mimicking the CD4 binding region of the envelope, protects rhesus macaques from intrarectal infection with the highly pathogenic SIVmac251. Using trend analysis, significant reductions in acute-phase and set point viremia were correlated with anti-gp120 antibody and cellular immune responses, respectively. Within immunization groups exhibiting significant protection, a subset (39%) of macaques have exhibited either no viremia, cleared viremia, or controlled viremia at the threshold of detection, now more than 40 weeks postchallenge. This combination prime-boost strategy, utilizing replication competent adenovirus, is a promising alternative for HIV vaccine development.Keywords
This publication has 59 references indexed in Scilit:
- Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) env/rev , gag , and/or nef Vaccines and Boosted with SIV gp120Journal of Virology, 2003
- Improved Protection of Rhesus Macaques against Intrarectal Simian Immunodeficiency Virus SIVmac251Challenge by a Replication-Competent Ad5hr-SIVenv/revand Ad5hr-SIVgagRecombinant Priming/gp120 Boosting RegimenJournal of Virology, 2003
- A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIVmac251 challenge in Rhesus MacaquesVaccine, 2003
- Boosting of SIV-Specific T Cell Responses in Rhesus Macaques That Resist Repeated Intravaginal Challenge with SIVmac251AIDS Research and Human Retroviruses, 2002
- Characterization of CD4+ T helper cell fine specificity to the envelope glycoproteins of simian immunodeficiency virusJournal of Medical Primatology, 2002
- Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239Journal of Virology, 2002
- Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus VectorsJournal of Virology, 2001
- A Conformational C4 Peptide Polymer Vaccine Coupled with Live Recombinant Vector Priming Is Immunogenic But Does Not Protect against Rectal SIV ChallengeAIDS Research and Human Retroviruses, 2001
- CD8+ Lymphocyte Antiviral Activity in Monkeys Immunized with SIV Recombinant Poxvirus Vaccines: Potential Role in Vaccine EfficacyAIDS Research and Human Retroviruses, 1999
- Immunogenicity of Recombinant Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees Following Intranasal AdministrationAIDS Research and Human Retroviruses, 1994